Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
Primary Purpose
Appetite and General Nutritional Disorders, Hormone Replacement
Status
Completed
Phase
Phase 1
Locations
Switzerland
Study Type
Interventional
Intervention
lactisole
Sponsored by
About this trial
This is an interventional basic science trial for Appetite and General Nutritional Disorders
Eligibility Criteria
Inclusion Criteria:
- Healthy subjects
- BMI of 19.0-24.5
- Age 18-40
- stable body weight for at least 3 month
Exclusion Criteria:
- smoking
- substance abuse
- regular intake of medication
- medical or psychiatric illness
- gastrointestinal disorders or food allergies
Sites / Locations
- University Hospital Basel, Clinical Research Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
Arm Label
75 g glucose + 150 ppm lactisole
75 g glucose + 300 ppm lactisole
75 g glucose + 450 ppm lactisole
75 g glucose
Arm Description
Outcomes
Primary Outcome Measures
Gastrointestinal peptide secretion
Secondary Outcome Measures
Full Information
NCT ID
NCT01088841
First Posted
March 16, 2010
Last Updated
February 22, 2011
Sponsor
University Hospital, Basel, Switzerland
1. Study Identification
Unique Protocol Identification Number
NCT01088841
Brief Title
Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
Official Title
The Functional Significance of Gut-expressed Taste Receptors in the Secretion of Glucagon-like Peptide-1 and Peptide YY
Study Type
Interventional
2. Study Status
Record Verification Date
February 2011
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
January 2010 (Actual)
Study Completion Date
March 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital, Basel, Switzerland
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the functional significance of sweet taste receptors in the secretion of GI satiety peptides by using a specific sweet taste receptor antagonist to block sweet taste perception in the gut.
Detailed Description
There is strong evidence that taste signaling mechanisms identified in the oral epithelium also operate in the gut. It is suggested that open-type enteroendocrine cells directly sense nutrient via alpha-gustducin coupled taste receptors to modulate the secretion of glucagon like peptide-1 (GLP-1) and peptide YY (PYY). Several nutrient responsive G-protein coupled receptors have been identified in the human gut, including the sweet taste responsive T1R2/T1R3 heterodimer, the amino acid/umami responsive T1R1/T1R3 as well as GPR120 for unsaturated long-chain free fatty acids.The functional significance of sweet taste receptors in glucose stimulated secretion of GLP-1 and PYY will be determined by intragastric infusion of 75 g glucose with different concentrations of lactisole (150 ppm, 300 ppm and 450 ppm)in a double blind, 4-way crossover trial including 16 healthy subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Appetite and General Nutritional Disorders, Hormone Replacement
7. Study Design
Primary Purpose
Basic Science
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
16 (Actual)
8. Arms, Groups, and Interventions
Arm Title
75 g glucose + 150 ppm lactisole
Arm Type
Active Comparator
Arm Title
75 g glucose + 300 ppm lactisole
Arm Type
Active Comparator
Arm Title
75 g glucose + 450 ppm lactisole
Arm Type
Active Comparator
Arm Title
75 g glucose
Arm Type
Placebo Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
lactisole
Other Intervention Name(s)
Glucose, water
Intervention Description
lactisole (flavoring agent/sweet taste antagonist) dissolved with 75 g glucose in 300 mL tap water; administered via intragastric tube
Primary Outcome Measure Information:
Title
Gastrointestinal peptide secretion
Time Frame
2 hours blood sampling
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy subjects
BMI of 19.0-24.5
Age 18-40
stable body weight for at least 3 month
Exclusion Criteria:
smoking
substance abuse
regular intake of medication
medical or psychiatric illness
gastrointestinal disorders or food allergies
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph Beglinger, MD
Organizational Affiliation
Clinical Research Center, University Hospital Basel
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Basel, Clinical Research Center
City
Basel
ZIP/Postal Code
4031
Country
Switzerland
12. IPD Sharing Statement
Learn more about this trial
Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
We'll reach out to this number within 24 hrs